| Basics |
AngioDynamics, Inc.
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
|
| IPO Date: |
June 1, 2004 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$393.89M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 1.74%
|
| Avg Daily Range (30 D): |
$0.19 | 1.99%
|
| Avg Daily Range (90 D): |
$0.22 | 2.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.21M |
| Avg Daily Volume (30 D): |
.41M |
| Avg Daily Volume (90 D): |
.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
104 |
| Avg Trade Size (Sh.) (30 D): |
71 |
| Avg Trade Size (Sh.) (90 D): |
71 |
| Institutional Trades |
| Total Inst.Trades: |
1,354 |
| Avg Inst. Trade: |
$1.16M |
| Avg Inst. Trade (30 D): |
$.93M |
| Avg Inst. Trade (90 D): |
$.74M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.16M |
| Avg Closing Trade (30 D): |
$.92M |
| Avg Closing Trade (90 D): |
$.74M |
| Avg Closing Volume: |
77.12K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.01
|
$-.11
|
$-.26
|
|
Diluted EPS
|
$-1.01
|
$-.11
|
$-.26
|
|
Revenue
|
$ 283.32M
|
$ 72M
|
$ 72.85M
|
|
Gross Profit
|
$ 154M
|
$ 38.86M
|
$ 39.91M
|
|
Net Income / Loss
|
$ -41.39M
|
$ -4.41M
|
$ -10.74M
|
|
Operating Income / Loss
|
$ -48.62M
|
$ -9.97M
|
$ -11.09M
|
|
Cost of Revenue
|
$ 129.32M
|
$ 33.15M
|
$ 32.94M
|
|
Net Cash Flow
|
$ -33.69M
|
$ -9.33M
|
$ -.92M
|
|
PE Ratio
|
|
|
|
|
|
|
